Indications
Therapeutic Asset Ratings
9,920 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pembrolizumab
Ovarian Clear Cell Tumor
HonorHealth Research Institute
P1
CC
(43)
Pembrolizumab
Long COVID-19
National Institute of Neurological Disorders and Stroke (NINDS)
P1
CC
(43)
Pembrolizumab
Autoimmune Pulmonary Disease Due To PD-1 Deficiency
Merck Sharp & Dohme LLC
P1
CC
(43)
Pembrolizumab
Prostate Neuroendocrine Neoplasm
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Pembrolizumab
Childhood Ependymoma
National Cancer Institute (NCI)
P1
CC
(43)
Pembrolizumab
Diffuse Intrinsic Pontine Glioma
National Cancer Institute (NCI)
P1
CC
(43)
Pembrolizumab
Medulloblastoma
National Cancer Institute (NCI)
P1
CC
(43)
Pembrolizumab
Ependymoma
National Cancer Institute (NCI)
P1
CC
(43)
Pembrolizumab
Retinoblastoma
Seattle Children's Hospital
P1
CC
(43)
Pembrolizumab
Rhabdoid Tumor
Seattle Children's Hospital
P1
CC
(43)
Pembrolizumab
Rhabdomyosarcoma
Seattle Children's Hospital
P1
CC
(43)
Pembrolizumab
Hypercalcemic Type Ovarian Small Cell Carcinoma
HonorHealth Research Institute
P1
CC
(43)
Pembrolizumab
Sebaceous Adenocarcinoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Pembrolizumab
SMARCA4-Deficient Sarcoma Of Thorax
Eli Lilly and Company
P1
CC
(43)
Pembrolizumab
Solitary Fibrous Tumor
Epkin
P1
CC
(43)
Pembrolizumab
Anal Canal Squamous Cell Carcinoma
Bicara Therapeutics
P1
CC
(43)
Pembrolizumab
Undifferentiated Pleomorphic Sarcoma
Epkin
P1
CC
(43)
Pembrolizumab
Ureter Small Cell Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(43)
Pembrolizumab
Wilms Tumor
Seattle Children's Hospital
P1
CC
(43)
Pentostatin
Hemoglobinopathy
City of Hope Medical Center
P1
CC
(43)
Pepticrad-1
Myxoid Liposarcoma
Valo Therapeutics Oy
P1
CC
(43)
Pepticrad-1
Synovial Sarcoma
Valo Therapeutics Oy
P1
CC
(43)
Personalized Neoantigen Tumor Vaccine
B-Cell Non-Hodgkin Lymphoma
Ruijin Hospital
P1
CC
(43)
Pertuzumab
Metastatic Malignant Neoplasm
Seoul National University Bundang Hospital
P1
CC
(43)
Pevonedistat
B-Cell Prolymphocytic Leukemia
City of Hope Medical Center
P1
CC
(43)
Showing 3801 to 3825 of 9,920 assets
Previous
Page 153 of 397
Next